Spyre Therapeutics, Inc. (SYRE): 424B5 filed Oct 5, 2026

Form type
424B5
Filing date
Oct 5, 2026
Accession number
0001628280-26-064924
Filer
Spyre Therapeutics, Inc. (CIK 1636282)